Morita T
Department of Urology, Tokyo Medical and Dental University School of Medicine.
J Smooth Muscle Res. 1991 Jun;27(3):149-54. doi: 10.1540/jsmr.27.149.
The adrenergic alpha-1 and -2 adrenoceptors in human hypertrophied and non-hypertrophied prostatic adenomas were measured in the saturation experiment using 3H-prazosin and 3H-yohimbine. Not only alpha-1 adrenoceptor but also alpha-2 adrenoceptor were found to exist with great amount in prostatic adenomas. In the inhibition experiment selective alpha-1 antagonists, prazosin and terazosin inhibited the 3H-prazosin or 3H-yohimbine bindings to prostatic adenomas. The ability as alpha-1 antagonist is ten times greater in prazosin than in terazosin, but that as alpha-2 antagonist is greater in terazosin than in prazosin. These data suggest that terazosin may have other effects than the relaxation of prostatic smooth muscles in hypertrophied prostatic adenoma.
采用³H-哌唑嗪和³H-育亨宾通过饱和实验测定人前列腺增生和未增生腺瘤中的肾上腺素能α-1和α-2肾上腺素受体。结果发现,不仅α-1肾上腺素受体,α-2肾上腺素受体在前列腺腺瘤中也大量存在。在抑制实验中,选择性α-1拮抗剂哌唑嗪和特拉唑嗪抑制³H-哌唑嗪或³H-育亨宾与前列腺腺瘤的结合。哌唑嗪作为α-1拮抗剂的能力比特拉唑嗪强10倍,但作为α-2拮抗剂的能力特拉唑嗪比哌唑嗪更强。这些数据表明,特拉唑嗪在前列腺增生腺瘤中除了使前列腺平滑肌松弛外可能还有其他作用。